These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23649458)

  • 21. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
    Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn's disease: a systematic review.
    El-Hussuna A; Krag A; Olaison G; Bendtsen F; Gluud LL
    Dis Colon Rectum; 2013 Dec; 56(12):1423-33. PubMed ID: 24201398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Schad CA; Haac BE; Cross RK; Syed A; Lonsako S; Bafford AC
    Dig Dis Sci; 2019 Jul; 64(7):1959-1966. PubMed ID: 30684075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.
    Yamamoto T; Spinelli A; Suzuki Y; Saad-Hossne R; Teixeira FV; de Albuquerque IC; da Silva RN; de Barcelos IF; Takeuchi K; Yamada A; Shimoyama T; da Silva Kotze LM; Sacchi M; Danese S; Kotze PG
    United European Gastroenterol J; 2016 Dec; 4(6):784-793. PubMed ID: 28408996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
    Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Morbidity Risks Following Ileocolic Resection for Crohn's Disease Treated With Anti-TNF Alpha Therapy: A Retrospective Study of 360 Patients.
    Jouvin I; Lefevre JH; Creavin B; Pitel S; Chafai N; Tiret E; Beaugerie L; Parc Y;
    Inflamm Bowel Dis; 2018 Jan; 24(2):422-432. PubMed ID: 29361093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery.
    Resegotti A; Astegiano M; Farina EC; Ciccone G; Avagnina G; Giustetto A; Campra D; Fronda GR
    Dis Colon Rectum; 2005 Mar; 48(3):464-8. PubMed ID: 15719193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of risk factors on the safety of ileocolic anastomosis in Crohn's disease surgery.
    Tzivanakis A; Singh JC; Guy RJ; Travis SP; Mortensen NJ; George BD
    Dis Colon Rectum; 2012 May; 55(5):558-62. PubMed ID: 22513434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
    Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
    J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressed Patients with Crohn's Disease Are at Increased Risk of Postoperative Complications: Results from the ACS-NSQIP Database.
    Abou Khalil M; Abou-Khalil J; Motter J; Vasilevsky CA; Morin N; Ghitulescu G; Boutros M
    J Gastrointest Surg; 2019 Jun; 23(6):1188-1197. PubMed ID: 30887300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study.
    de Barcelos IF; Kotze PG; Spinelli A; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; da Silva Kotze LM; Yamamoto T
    Colorectal Dis; 2017 Jan; 19(1):O39-O45. PubMed ID: 27943564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparable outcomes of the consistent use versus switched use of anti- tumor necrosis factor agents in postoperative recurrent Crohn's disease following ileocolonic resection.
    Li Y; Stocchi L; Rui Y; Remzi FH; Shen B
    Int J Colorectal Dis; 2016 Nov; 31(11):1751-1758. PubMed ID: 27475090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    Shah RS; Bachour S; Jia X; Holubar SD; Hull TL; Achkar JP; Philpott J; Qazi T; Rieder F; Cohen BL; Regueiro MD; Lightner AL; Click BH
    J Crohns Colitis; 2021 Jul; 15(7):1142-1151. PubMed ID: 33388775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn's disease.
    Ahmed Ali U; Martin ST; Rao AD; Kiran RP
    Dis Colon Rectum; 2014 May; 57(5):663-74. PubMed ID: 24819109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn's disease: who is at risk?
    Riss S; Bittermann C; Zandl S; Kristo I; Stift A; Papay P; Vogelsang H; Mittlböck M; Herbst F
    Colorectal Dis; 2010 Oct; 12(10 Online):e298-303. PubMed ID: 20041915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic approach in patients with recurrent Crohn's disease.
    Huang R; Valerian BT; Lee EC
    Am Surg; 2012 May; 78(5):595-9. PubMed ID: 22546134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.
    Zuo L; Li Y; Wang H; Zhu W; Zhang W; Gong J; Li N; Li J
    Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar outcomes of surgical and medical treatment of intra-abdominal abscesses in patients with Crohn's disease.
    Nguyen DL; Sandborn WJ; Loftus EV; Larson DW; Fletcher JG; Becker B; Mandrekar J; Harmsen WS; Bruining DH
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):400-4. PubMed ID: 22155562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.